| Year |
Citation |
Score |
| 2024 |
Xue L, Zhao G, Gong N, Han X, Shepherd SJ, Xiong X, Xiao Z, Palanki R, Xu J, Swingle KL, Warzecha CC, El-Mayta R, Chowdhary V, Yoon IC, Xu J, ... ... Mitchell MJ, et al. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nature Nanotechnology. PMID 39354147 DOI: 10.1038/s41565-024-01747-6 |
0.301 |
|
| 2024 |
Kim EH, Teerdhala SV, Padilla MS, Joseph RA, Li JJ, Haley RM, Mitchell MJ. Lipid nanoparticle-mediated RNA delivery for immune cell modulation. European Journal of Immunology. e2451008. PMID 39279550 DOI: 10.1002/eji.202451008 |
0.357 |
|
| 2024 |
Palanki R, Riley JS, Bose SK, Luks V, Dave A, Kus N, White BM, Ricciardi AS, Swingle KL, Xue L, Sung D, Thatte AS, Safford HC, Chaluvadi VS, Carpenter M, ... ... Mitchell MJ, et al. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 121: e2400783121. PMID 39078677 DOI: 10.1073/pnas.2400783121 |
0.725 |
|
| 2024 |
Palanki R, Han EL, Murray AM, Maganti R, Tang S, Swingle KL, Kim D, Yamagata H, Safford HC, Mrksich K, Peranteau WH, Mitchell MJ. Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing. Lab On a Chip. PMID 39037068 DOI: 10.1039/d4lc00283k |
0.312 |
|
| 2024 |
Hamilton AG, Swingle KL, Thatte AS, Mukalel AJ, Safford HC, Billingsley MM, El-Mayta RD, Han X, Nachod BE, Joseph RA, Metzloff AE, Mitchell MJ. High-Throughput Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route. Acs Nano. PMID 38861479 DOI: 10.1021/acsnano.4c01171 |
0.801 |
|
| 2024 |
Geisler HC, Ghalsasi AA, Safford HC, Swingle KL, Thatte AS, Mukalel AJ, Gong N, Hamilton AG, Han EL, Nachod BE, Padilla MS, Mitchell MJ. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 38789090 DOI: 10.1016/j.jconrel.2024.05.036 |
0.794 |
|
| 2024 |
Atsavapranee E, Haley RM, Billingsley MM, Chan A, Ruan B, Figueroa-Espada CG, Gong N, Mukalel AJ, Bryan PN, Mitchell MJ. Ionizable lipid nanoparticles for RAS protease delivery to inhibit cancer cell proliferation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 38729436 DOI: 10.1016/j.jconrel.2024.05.015 |
0.794 |
|
| 2024 |
Gong N, Han X, Xue L, Billingsley MM, Huang X, El-Mayta R, Qin J, Sheppard NC, June CH, Mitchell MJ. Author Correction: Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager. Nature Biomedical Engineering. PMID 38491330 DOI: 10.1038/s41551-024-01198-3 |
0.678 |
|
| 2024 |
Xue L, Hamilton AG, Zhao G, Xiao Z, El-Mayta R, Han X, Gong N, Xiong X, Xu J, Figueroa-Espada CG, Shepherd SJ, Mukalel AJ, Alameh MG, Cui J, Wang K, ... ... Mitchell MJ, et al. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models. Nature Communications. 15: 1884. PMID 38424061 DOI: 10.1038/s41467-024-45422-9 |
0.8 |
|
| 2024 |
Metzloff AE, Padilla MS, Gong N, Billingsley MM, Han X, Merolle M, Mai D, Figueroa-Espada CG, Thatte AS, Haley RM, Mukalel AJ, Hamilton AG, Alameh MG, Weissman D, Sheppard NC, ... ... Mitchell MJ, et al. Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e2313226. PMID 38419362 DOI: 10.1002/adma.202313226 |
0.799 |
|
| 2024 |
Gong N, Han X, Xue L, Billingsley MM, Huang X, El-Mayta R, Qin J, Sheppard NC, June CH, Mitchell MJ. Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager. Nature Biomedical Engineering. PMID 38378820 DOI: 10.1038/s41551-023-01147-6 |
0.697 |
|
| 2024 |
Thatte AS, Billingsley MM, Weissman D, Melamed JR, Mitchell MJ. Emerging strategies for nanomedicine in autoimmunity. Advanced Drug Delivery Reviews. 207: 115194. PMID 38342243 DOI: 10.1016/j.addr.2024.115194 |
0.702 |
|
| 2024 |
Guimaraes LC, Costa PAC, Scalzo Júnior SRA, Ferreira HAS, Braga ACS, de Oliveira LC, Figueiredo MM, Shepherd S, Hamilton A, Queiroz-Junior CM, da Silva WN, da Silva NJA, Rodrigues Alves MT, Santos AK, de Faria KKS, ... ... Mitchell MJ, et al. Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models. Nature Communications. 15: 590. PMID 38238326 DOI: 10.1038/s41467-024-44830-1 |
0.679 |
|
| 2024 |
Patel SK, Billingsley MM, Mukalel AJ, Thatte AS, Hamilton AG, Gong N, El-Mayta R, Safford HC, Merolle M, Mitchell MJ. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery. Theranostics. 14: 1-16. PMID 38164140 DOI: 10.7150/thno.89913 |
0.804 |
|
| 2023 |
Mossburg KJ, Shepherd SJ, Barragan D, O NH, Berkow EK, Maidment PSN, Berrios DNR, Hsu JC, Siedlik MJ, Yadavali S, Mitchell MJ, Issadore D, Cormode DP. Towards the Clinical Translation of a Silver Sulfide Nanoparticle Contrast Agent: Large Scale Production with a Highly Parallelized Microfluidic Chip. Biorxiv : the Preprint Server For Biology. PMID 38106126 DOI: 10.1101/2023.12.02.569706 |
0.655 |
|
| 2023 |
Billingsley MM, Gong N, Mukalel AJ, Thatte AS, El-Mayta R, Patel SK, Metzloff AE, Swingle KL, Han X, Xue L, Hamilton AG, Safford HC, Alameh MG, Papp TE, Parhiz H, ... ... Mitchell MJ, et al. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism. Small (Weinheim An Der Bergstrasse, Germany). e2304378. PMID 38072809 DOI: 10.1002/smll.202304378 |
0.812 |
|
| 2023 |
Thatte AS, Hamilton AG, Nachod BE, Mukalel AJ, Billingsley MM, Palanki R, Swingle KL, Mitchell MJ. mRNA Lipid Nanoparticles for Engineering of Immunosuppressive T Cells for Autoimmunity Therapies. Nano Letters. PMID 37906000 DOI: 10.1021/acs.nanolett.3c02573 |
0.79 |
|
| 2023 |
Prazeres PHDM, Ferreira H, Costa PAC, da Silva W, Alves MT, Padilla M, Thatte A, Santos AK, Lobo AO, Sabino A, Del Puerto HL, Mitchell MJ, Guimaraes PPG. Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells. International Journal of Nanomedicine. 18: 5891-5904. PMID 37873551 DOI: 10.2147/IJN.S424723 |
0.306 |
|
| 2023 |
Figueroa-Espada CG, Guimarães PPG, Riley RS, Xue L, Wang K, Mitchell MJ. siRNA Lipid-Polymer Nanoparticles Targeting E-Selectin and Cyclophilin A in Bone Marrow for Combination Multiple Myeloma Therapy. Cellular and Molecular Bioengineering. 16: 383-392. PMID 37810998 DOI: 10.1007/s12195-023-00774-y |
0.693 |
|
| 2023 |
Gong N, Han X, Xue L, El-Mayta R, Metzloff AE, Billingsley MM, Hamilton AG, Mitchell MJ. In situ PEGylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity. Nature Materials. PMID 37696939 DOI: 10.1038/s41563-023-01646-6 |
0.701 |
|
| 2023 |
Hamilton AG, Swingle KL, Joseph RA, Mai D, Gong N, Billingsley MM, Alameh MG, Weissman D, Sheppard NC, June CH, Mitchell MJ. Lonizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering. Advanced Healthcare Materials. e2301515. PMID 37602495 DOI: 10.1002/adhm.202301515 |
0.726 |
|
| 2023 |
Shepherd SJ, Han X, Mukalel AJ, El-Mayta R, Thatte AS, Wu J, Padilla MS, Alameh MG, Srikumar N, Lee D, Weissman D, Issadore D, Mitchell MJ. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines. Proceedings of the National Academy of Sciences of the United States of America. 120: e2303567120. PMID 37556502 DOI: 10.1073/pnas.2303567120 |
0.785 |
|
| 2023 |
Safford HC, Swingle KL, Geisler HC, Hamilton AG, Thatte AS, Ghalsasi AA, Billingsley MM, Alameh MG, Weissman D, Mitchell MJ. Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta. Small (Weinheim An Der Bergstrasse, Germany). e2303568. PMID 37537704 DOI: 10.1002/smll.202303568 |
0.735 |
|
| 2023 |
Palanki R, Bose SK, Dave A, White BM, Berkowitz C, Luks V, Yaqoob F, Han E, Swingle KL, Menon P, Hodgson E, Biswas A, Billingsley MM, Li L, Yiping F, ... ... Mitchell MJ, et al. Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease. Acs Nano. PMID 37458484 DOI: 10.1021/acsnano.3c02268 |
0.703 |
|
| 2023 |
Nong J, Glassman PM, Myerson JW, Zuluaga-Ramirez V, Rodriguez-Garcia A, Mukalel A, Omo-Lamai S, Walsh LR, Zamora ME, Gong X, Wang Z, Bhamidipati K, Kiseleva RY, Villa CH, Greineder CF, ... ... Mitchell MJ, et al. Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain. Acs Nano. PMID 37432926 DOI: 10.1021/acsnano.2c08275 |
0.764 |
|
| 2023 |
Guimarães PPG, Figueroa-Espada CG, Riley RS, Gong N, Xue L, Sewastianik T, Dennis PS, Loebel C, Chung A, Shepherd SJ, Haley RM, Hamilton AG, El-Mayta R, Wang K, Langer R, ... ... Mitchell MJ, et al. In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy. Proceedings of the National Academy of Sciences of the United States of America. 120: e2215711120. PMID 37310997 DOI: 10.1073/pnas.2215711120 |
0.786 |
|
| 2023 |
Haley RM, Chan A, Billingsley MM, Gong N, Padilla MS, Kim EH, Wang H, Yin D, Wangensteen KJ, Tsourkas A, Mitchell MJ. Lipid Nanoparticle Delivery of Small Proteins for Potent RAS Inhibition. Acs Applied Materials & Interfaces. PMID 37115558 DOI: 10.1021/acsami.3c01501 |
0.7 |
|
| 2023 |
McDonald CL, Qasba P, Anderson DG, Bao G, Colvin RA, Kohn DB, Malik P, Mitchell MJ, Pu WT, Rawlings DJ, Williams DA, Flotte TR. Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop. Human Gene Therapy. 34: 83-89. PMID 36794978 DOI: 10.1089/hum.2022.29233.tga |
0.317 |
|
| 2023 |
Swingle KL, Safford HC, Geisler HC, Hamilton AG, Thatte AS, Billingsley MM, Joseph RA, Mrksich K, Padilla MS, Ghalsasi AA, Alameh MG, Weissman D, Mitchell MJ. Ionizable Lipid Nanoparticles for mRNA Delivery to the Placenta during Pregnancy. Journal of the American Chemical Society. PMID 36789893 DOI: 10.1021/jacs.2c12893 |
0.727 |
|
| 2023 |
El-Mayta R, Padilla MS, Billingsley MM, Han X, Mitchell MJ. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing. Journal of Visualized Experiments : Jove. PMID 36744791 DOI: 10.3791/64810 |
0.723 |
|
| 2023 |
Bashiri G, Padilla MS, Swingle KL, Shepherd SJ, Mitchell MJ, Wang K. Nanoparticle protein corona: from structure and function to therapeutic targeting. Lab On a Chip. PMID 36655824 DOI: 10.1039/d2lc00799a |
0.657 |
|
| 2023 |
Han X, Gong N, Xue L, Billingsley MM, El-Mayta R, Shepherd SJ, Alameh MG, Weissman D, Mitchell MJ. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nature Communications. 14: 75. PMID 36650129 DOI: 10.1038/s41467-022-35637-z |
0.797 |
|
| 2022 |
Butowska K, Han X, Gong N, El-Mayta R, Haley RM, Xue L, Zhong W, Guo W, Wang K, Mitchell MJ. Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy. Acta Pharmaceutica Sinica. B. 13: 1429-1437. PMID 37139433 DOI: 10.1016/j.apsb.2022.07.011 |
0.307 |
|
| 2022 |
Qin J, Xue L, Gong N, Zhang H, Shepherd SJ, Haley RM, Swingle KL, Mitchell MJ. RGD peptide-based lipids for targeted mRNA delivery and gene editing applications. Rsc Advances. 12: 25397-25404. PMID 36199352 DOI: 10.1039/d2ra02771b |
0.716 |
|
| 2022 |
Xue L, Gong N, Shepherd SJ, Xiong X, Liao X, Han X, Zhao G, Song C, Huang X, Zhang H, Padilla MS, Qin J, Shi Y, Alameh MG, Pochan DJ, ... ... Mitchell MJ, et al. Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment. Journal of the American Chemical Society. PMID 35616998 DOI: 10.1021/jacs.2c02706 |
0.666 |
|
| 2022 |
Patel SK, Billingsley MM, Frazee C, Han X, Swingle KL, Qin J, Alameh MG, Wang K, Weissman D, Mitchell MJ. Hydroxycholesterol substitution in Ionizable lipid nanoparticles for mRNA delivery to T cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 35569584 DOI: 10.1016/j.jconrel.2022.05.020 |
0.757 |
|
| 2022 |
Metzloff AE, Billingsley MM, Mitchell MJ. Lighting the way to personalized mRNA immune cell therapies. Science Advances. 8: eabo2423. PMID 35196095 DOI: 10.1126/sciadv.abo2423 |
0.703 |
|
| 2022 |
Zhang H, Han X, Alameh MG, Shepherd SJ, Padilla MS, Xue L, Butowska K, Weissman D, Mitchell MJ. Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery. Journal of Biomedical Materials Research. Part A. PMID 35076171 DOI: 10.1002/jbm.a.37356 |
0.7 |
|
| 2021 |
Parhiz H, Brenner JS, Patel P, Papp TE, Shahnawaz H, Li Q, Shi R, Zamora M, Yadegari A, Marcos-Contreras OA, Natesan A, Pardi N, Shuvaev VV, Kiseleva R, Myerson J, ... ... Mitchell MJ, et al. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE). Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34953981 DOI: 10.1016/j.jconrel.2021.12.027 |
0.697 |
|
| 2021 |
Swingle KL, Billingsley MM, Bose SK, White B, Palanki R, Dave A, Patel SK, Gong N, Hamilton AG, Alameh MG, Weissman D, Peranteau WH, Mitchell MJ. Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34742747 DOI: 10.1016/j.jconrel.2021.10.031 |
0.727 |
|
| 2021 |
Billingsley MM, Hamilton AG, Mai D, Patel SK, Swingle KL, Sheppard NC, June CH, Mitchell MJ. Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells. Nano Letters. PMID 34669421 DOI: 10.1021/acs.nanolett.1c02503 |
0.749 |
|
| 2021 |
Zhang D, Atochina-Vasserman EN, Maurya DS, Huang N, Xiao Q, Ona N, Liu M, Shahnawaz H, Ni H, Kim K, Billingsley MM, Pochan DJ, Mitchell MJ, Weissman D, Percec V. One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA. Journal of the American Chemical Society. PMID 34324336 DOI: 10.1021/jacs.1c05813 |
0.73 |
|
| 2021 |
Shepherd SJ, Warzecha CC, Yadavali S, El-Mayta R, Alameh MG, Wang L, Weissman D, Wilson JM, Issadore D, Mitchell MJ. Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device. Nano Letters. PMID 34189917 DOI: 10.1021/acs.nanolett.1c01353 |
0.7 |
|
| 2021 |
Shepherd SJ, Issadore D, Mitchell MJ. Microfluidic formulation of nanoparticles for biomedical applications. Biomaterials. 274: 120826. PMID 33965797 DOI: 10.1016/j.biomaterials.2021.120826 |
0.671 |
|
| 2021 |
Atsavapranee ES, Billingsley MM, Mitchell MJ. Delivery technologies for T cell gene editing: Applications in cancer immunotherapy. Ebiomedicine. 67: 103354. PMID 33910123 DOI: 10.1016/j.ebiom.2021.103354 |
0.716 |
|
| 2021 |
Riley RS, Kashyap MV, Billingsley MM, White B, Alameh MG, Bose SK, Zoltick PW, Li H, Zhang R, Cheng AY, Weissman D, Peranteau WH, Mitchell MJ. Ionizable lipid nanoparticles for in utero mRNA delivery. Science Advances. 7. PMID 33523869 DOI: 10.1126/sciadv.aba1028 |
0.815 |
|
| 2021 |
Gong N, Sheppard NC, Billingsley MM, June CH, Mitchell MJ. Nanomaterials for T-cell cancer immunotherapy. Nature Nanotechnology. 16: 25-36. PMID 33437036 DOI: 10.1038/s41565-020-00822-y |
0.712 |
|
| 2021 |
Zhang R, El-Mayta R, Murdoch TJ, Warzecha CC, Billingsley MM, Shepherd SJ, Gong N, Wang L, Wilson JM, Lee D, Mitchell MJ. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomaterials Science. PMID 33404020 DOI: 10.1039/d0bm01609h |
0.804 |
|
| 2020 |
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nature Reviews. Drug Discovery. PMID 33277608 DOI: 10.1038/s41573-020-0090-8 |
0.735 |
|
| 2020 |
Krohn-Grimberghe M, Mitchell MJ, Schloss MJ, Khan OF, Courties G, Guimaraes PPG, Rohde D, Cremer S, Kowalski PS, Sun Y, Tan M, Webster J, Wang K, Iwamoto Y, Schmidt SP, et al. Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche. Nature Biomedical Engineering. PMID 33020600 DOI: 10.1038/s41551-020-00623-7 |
0.527 |
|
| 2020 |
Figueroa-Espada CG, Mitchell MJ, Riley RS. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy. Advanced Drug Delivery Reviews. PMID 32956719 DOI: 10.1016/J.Addr.2020.09.006 |
0.719 |
|
| 2020 |
Choueiri TK, Atkins MB, Bakouny Z, Carlo MI, Drake CG, Jonasch E, Kapur P, Lewis B, Linehan WM, Mitchell MJ, Pal SK, Pels K, Poteat S, Rathmell WK, Rini BI, et al. Summary from the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research. Journal of the National Cancer Institute. PMID 32359162 DOI: 10.1093/Jnci/Djaa064 |
0.307 |
|
| 2020 |
Haley RM, Gottardi R, Langer R, Mitchell MJ. Cyclodextrins in drug delivery: applications in gene and combination therapy. Drug Delivery and Translational Research. PMID 32077052 DOI: 10.1007/S13346-020-00724-5 |
0.456 |
|
| 2020 |
Billingsley M, Singh N, Ravikumar P, Zhang R, June CH, Mitchell MJ. Ionizable Lipid Nanoparticle Mediated mRNA Delivery for Human CAR T Cell Engineering. Nano Letters. PMID 31951421 DOI: 10.1021/Acs.Nanolett.9B04246 |
0.765 |
|
| 2019 |
Yeom J, Guimaraes PPG, Ahn HM, Jung BK, Hu Q, McHugh K, Mitchell MJ, Yun CO, Langer R, Jaklenec A. Chiral Supraparticles for Controllable Nanomedicine. Advanced Materials (Deerfield Beach, Fla.). e1903878. PMID 31686433 DOI: 10.1002/Adma.201903878 |
0.42 |
|
| 2019 |
Guimaraes PP, Zhang R, Spektor R, Tan M, Chung A, Billingsley MM, El-Mayta R, Riley RS, Wang L, Wilson JM, Mitchell MJ. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31678653 DOI: 10.1016/J.Jconrel.2019.10.028 |
0.808 |
|
| 2019 |
Mukalel AJ, Riley RS, Zhang R, Mitchell MJ. Nanoparticles for Nucleic Acid Delivery: Applications in Cancer Immunotherapy. Cancer Letters. PMID 31100411 DOI: 10.1016/J.Canlet.2019.04.040 |
0.809 |
|
| 2019 |
Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nature Reviews. Drug Discovery. PMID 30622344 DOI: 10.1038/S41573-018-0006-Z |
0.76 |
|
| 2018 |
Bisso PW, Gaglione S, Guimarães PPG, Mitchell MJ, Langer R. Nanomaterial Interactions with Human Neutrophils. Acs Biomaterials Science & Engineering. 4: 4255-4265. PMID 31497639 DOI: 10.1021/Acsbiomaterials.8B01062 |
0.408 |
|
| 2018 |
Mitchell MJ, Jain RK, Langer R. Publisher Correction: Engineering and physical sciences in oncology: challenges and opportunities. Nature Reviews. Cancer. PMID 30337715 DOI: 10.1038/S41568-018-0072-X |
0.337 |
|
| 2018 |
Zhang R, Billingsley MM, Mitchell MJ. Biomaterials for vaccine-based cancer immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30312721 DOI: 10.1016/J.Jconrel.2018.10.008 |
0.721 |
|
| 2018 |
Guimaraes PPG, Tan M, Tammela T, Wu K, Chung A, Oberli M, Wang K, Spektor R, Riley RS, Viana CTR, Jacks T, Langer R, Mitchell MJ. Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30290244 DOI: 10.1016/J.Jconrel.2018.09.025 |
0.718 |
|
| 2018 |
Fenton OS, Olafson KN, Pillai PS, Mitchell MJ, Langer R. Advances in Biomaterials for Drug Delivery. Advanced Materials (Deerfield Beach, Fla.). e1705328. PMID 29736981 DOI: 10.1002/Adma.201705328 |
0.439 |
|
| 2018 |
Guimaraes PPG, Gaglione S, Sewastianik T, Carrasco RD, Langer R, Mitchell MJ. Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy. Acs Nano. PMID 29378114 DOI: 10.1021/Acsnano.7B05876 |
0.518 |
|
| 2017 |
Mitchell MJ, Jain RK, Langer R. Engineering and physical sciences in oncology: challenges and opportunities. Nature Reviews. Cancer. PMID 29026204 DOI: 10.1038/Nrc.2017.83 |
0.403 |
|
| 2017 |
Nasajpour A, Mandla S, Shree S, Mostafavi E, Sharifi R, Khalilpour A, Saghazadeh S, Hassan S, Mitchell MJ, Leijten J, Hou X, Moshaverinia A, Annabi N, Adelung R, Mishra YK, et al. Nanostructured fibrous membranes with rose spike-like architecture. Nano Letters. PMID 28819978 DOI: 10.1021/Acs.Nanolett.7B02929 |
0.461 |
|
| 2017 |
Mitchell MJ, Webster J, Chung A, Guimarães PP, Khan OF, Langer R. Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis. Nature Communications. 8: 14179. PMID 28317839 DOI: 10.1038/Ncomms14179 |
0.452 |
|
| 2017 |
Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Letters. 17: 1326-1335. PMID 28273716 DOI: 10.1021/Acs.Nanolett.6B03329 |
0.6 |
|
| 2017 |
Mitchell MJ, Langer R. Abstract PR09: Polymeric mechanical amplifiers of tumor apoptosis Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-Pr09 |
0.34 |
|
| 2016 |
Mitchell MJ, Langer R. Abstract 3901: Polymeric mechanical amplifiers of tumor cell receptor-mediated apoptosis Cancer Research. 76: 3901-3901. DOI: 10.1158/1538-7445.Am2016-3901 |
0.411 |
|
| 2015 |
Wayne EC, Chandrasekaran S, Mitchell MJ, Chan MF, Lee RE, Schaffer CB, King MR. TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26732555 DOI: 10.1016/J.Jconrel.2015.12.048 |
0.482 |
|
| 2015 |
Mitchell MJ, Denais C, Chan M, Wang Z, Lammerding J, King MR. Lamin A/C Deficiency Reduces Circulating Tumor Cell Resistance to Fluid Shear Stress. American Journal of Physiology. Cell Physiology. ajpcell.00050.2015. PMID 26447202 DOI: 10.1152/Ajpcell.00050.2015 |
0.455 |
|
| 2015 |
Mitchell MJ, Castellanos CA, King MR. Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow. Biomaterials. 56: 179-86. PMID 25934290 DOI: 10.1016/J.Biomaterials.2015.03.045 |
0.493 |
|
| 2015 |
Mitchell MJ, Castellanos CA, King MR. Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies. Journal of Biomedical Materials Research. Part A. PMID 25761664 DOI: 10.1002/Jbm.A.35445 |
0.482 |
|
| 2015 |
Kohn JC, Zhou DW, Bordeleau F, Zhou AL, Mason BN, Mitchell MJ, King MR, Reinhart-King CA. Cooperative effects of matrix stiffness and fluid shear stress on endothelial cell behavior. Biophysical Journal. 108: 471-8. PMID 25650915 DOI: 10.1016/J.Bpj.2014.12.023 |
0.567 |
|
| 2015 |
Mitchell MJ, King MR. Leukocytes as carriers for targeted cancer drug delivery. Expert Opinion On Drug Delivery. 12: 375-92. PMID 25270379 DOI: 10.1517/17425247.2015.966684 |
0.524 |
|
| 2014 |
Bajpai S, Mitchell MJ, King MR, Reinhart-King CA. A microfluidic device to select for cells based on chemotactic phenotype. Technology. 2: 101-105. PMID 24999488 DOI: 10.1142/S2339547814200015 |
0.382 |
|
| 2014 |
Mitchell MJ, Lin KS, King MR. Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophysical Journal. 106: 2243-53. PMID 24853753 DOI: 10.1016/J.Bpj.2014.04.001 |
0.409 |
|
| 2014 |
Mitchell MJ, King MR. Unnatural killer cells to prevent bloodborne metastasis: inspiration from biology and engineering. Expert Review of Anticancer Therapy. 14: 641-4. PMID 24791860 DOI: 10.1586/14737140.2014.916619 |
0.515 |
|
| 2014 |
Mitchell MJ, Wayne E, Rana K, Schaffer CB, King MR. TRAIL-coated leukocytes that kill cancer cells in the circulation. Proceedings of the National Academy of Sciences of the United States of America. 111: 930-5. PMID 24395803 DOI: 10.1073/Pnas.1316312111 |
0.79 |
|
| 2014 |
Mitchell MJ, King MR. Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells. American Journal of Physiology. Cell Physiology. 306: C89-97. PMID 24133067 DOI: 10.1152/Ajpcell.00285.2013 |
0.488 |
|
| 2013 |
Mitchell MJ, King MR. Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors. New Journal of Physics. 15: 015008. PMID 25110459 DOI: 10.1088/1367-2630/15/1/015008 |
0.463 |
|
| 2013 |
Cao TM, Mitchell MJ, Liesveld J, King MR. Stem cell enrichment with selectin receptors: mimicking the pH environment of trauma. Sensors (Basel, Switzerland). 13: 12516-26. PMID 24048341 DOI: 10.3390/S130912516 |
0.455 |
|
| 2013 |
Mitchell MJ, King MR. Computational and experimental models of cancer cell response to fluid shear stress. Frontiers in Oncology. 3: 44. PMID 23467856 DOI: 10.3389/Fonc.2013.00044 |
0.459 |
|
| 2013 |
Mitchell MJ, King MR. Computational and experimental models of cancer cell response to fluid shear stress Frontiers in Oncology. 3. DOI: 10.3389/fonc.2013.00044 |
0.384 |
|
| 2013 |
Mitchell MJ, King MR. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors New Journal of Physics. 15. DOI: 10.1088/1367-2630/15/1/015008 |
0.389 |
|
| 2012 |
Mitchell MJ, Castellanos CA, King MR. Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes. Journal of Nanomaterials. 2012. PMID 25152752 DOI: 10.1155/2012/831263 |
0.514 |
|
| 2012 |
Mitchell MJ, King MR. Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophysical Journal. 102: 1804-14. PMID 22768936 DOI: 10.1016/j.bpj.2012.03.053 |
0.331 |
|
| 2012 |
Mitchell MJ, Chen CS, Ponmudi V, Hughes AD, King MR. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 160: 609-17. PMID 22421423 DOI: 10.1016/J.Jconrel.2012.02.018 |
0.67 |
|
| 2011 |
Mitchell MJ, King MR. Shear-induced resistance to neutrophil activation via the formyl peptide receptor 2011 Ieee 37th Annual Northeast Bioengineering Conference, Nebec 2011. DOI: 10.1109/NEBC.2011.5778708 |
0.328 |
|
| 2008 |
Ehrmann I, Dalgliesh C, Tsaousi A, Paronetto MP, Heinrich B, Kist R, Cairns P, Li W, Mueller C, Jackson M, Peters H, Nayernia K, Saunders P, Mitchell M, Stamm S, et al. Haploinsufficiency of the germ cell-specific nuclear RNA binding protein hnRNP G-T prevents functional spermatogenesis in the mouse. Human Molecular Genetics. 17: 2803-18. PMID 18562473 DOI: 10.1093/Hmg/Ddn179 |
0.353 |
|
| 1999 |
Sargent CA, Boucher CA, Kirsch S, Brown G, Weiss B, Trundley A, Burgoyne P, Saut N, Durand C, Levy N, Terriou P, Hargreave T, Cooke H, Mitchell M, Rappold GA, et al. The critical region of overlap defining the AZFa male infertility interval of proximal Yq contains three transcribed sequences. Journal of Medical Genetics. 36: 670-677. DOI: 10.1136/Jmg.36.9.670 |
0.316 |
|
| Show low-probability matches. |